SAN ANTONIO — In the course of caring for individuals with psoriasis, clinicians should have patients complete the validated ...

When added to optimized oral anti-lipid therapy, a PCSK9 blocker provided an additional 25% risk reduction in a first ...

Finerenone shows significant benefits in patients with kidney disease and type 1 diabetes, which could lead to the first ...

Substantial reductions in adverse cardiovascular outcomes are especially notable for this high-risk population, but ...

An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers ...

Given prior negative studies of fish oil supplements for CV prevention, the positive findings for PISCES in patients on ...

A higher-titer ANA raises the suspicion that something more systemic may be going on,’ said Amanda Mixon, PA-C.

In the absence of FDA-approved long COVID treatments, desperate patients look to alternative medicine. Here’s a look at what ...

Experts explore the messy intersection between evidence-based cancer care and an enticing wellness industry dominated by ...

Two open-label extension studies show that the FcRn blocker nipocalimab has durable efficacy and sustained symptom control ...

With greater understanding of the complex pathomechanisms of myalgic encephalomyelitis/chronic fatigue syndrome, researchers ...

Vague symptoms. Crazy blood pressure. Fruitless ER visits. Then suddenly, this doctor had stage IV cancer. Or maybe not. Her ...